Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.78 USD | +0.27% | -2.33% | -11.48% |
31/05 | Prelude Therapeutics Files for $400 Million Mixed Shelf | MT |
07/05 | Prelude Therapeutics Incorporated Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-11.48% | 207M | |
+55.55% | 59.34B | |
+43.17% | 40.24B | |
-4.71% | 39.88B | |
-5.56% | 28.55B | |
+13.76% | 27.26B | |
-22.00% | 19.23B | |
+31.50% | 12.61B | |
+2.16% | 12.49B | |
+25.70% | 12.28B |
- Stock Market
- Equities
- PRLD Stock
- News Prelude Therapeutics Incorporated
- Prelude Therapeutics to Proceed With Phase 1 Study of PRT3789 Product Candidate